Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zika virus has pandemic potential, scientists say
aedes mosquito
"PAHO anticipates that Zika virus will continue to spread and will likely reach all countries and territories of the region where Aedes mosquitos are found."
Virus thought likely to spread across the Americas

The emerging mosquito-borne Zika virus now has 'explosive' pandemic potential, according to US scientists.

Since it was reported in Brazil in May last year, it has spread to 21 countries in the Americas (as of 23 January, 2016). This is of particular concern as there is growing evidence to suggest it could be linked with incomplete brain development in newborn babies.

It is primarily transmitted by Aedes mosquitoes, which are present in all of the Americas except Canada and continental Chile, meaning the virus is likely to spread further.

The Pan American Health Organization (PAHO) said in a statement: "PAHO anticipates that Zika virus will continue to spread and will likely reach all countries and territories of the region where Aedes mosquitos are found."

Another reason for its rapid spread, according to PAHO, is that it is new to the population of the Americas and therefore they have no immunity to it.

Whilst it generally causes only mild illness in humans, health authorities are currently investigating a possible link with microcephaly (abnormal smallness of the head) in babies.

Since Brazil reported the virus in 2015, there have been over 3,500 suspected cases - a 20-fold increase from 2010 through to 2014.

There is currently no vaccine for Zika virus. PAHO, which is a regional office of the World Health Organisation (WHO), says it is helping countries of the Americas to prepare for any possible spread through vector control, better surveillance and communication of prevention methods.

But scientists from Georgetown University, Washington DC, have said that lessons must be learnt from the Ebola epidemic. In July last year, the WHO Ebola Panel found that urgent warnings either failed to reach senior leaders, or senior leaders did not realise their significance.

Writing in the Journal of the American Medical Association, the team from Georgetown said that while the WHO has said it is supporting countries to control Zika, it 'is still not taking a leadership role in the Zika pandemic'.

An IHR emergency committee should be convened immediately, they added, saying that while Brazil, PAHO and the Centers for Disease Control have acted quickly, WHO headquarters have so far 'not been proactive'.

For the full study visit: http://jama.jamanetwork.com/article.aspx?articleID=2485361
For more information on Zika virus, see: http://www.who.int/mediacentre/factsheets/zika/en/

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.